HTGC Stock Cash Flow Statements

Hercules Capital Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Hercules Capital Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2011-03-31	2010-06-30	2010-03-31	2009-09-30

cash flows from operating activities:
net increase in net assets resulting from operations	78,887,000	50,337,000	61,439,000	68,711,000	41,852,000	90,964,000	120,178,000	64,163,000	151,172,000	43,047,000	61,765,000	-28,723,000	44,611,000	19,271,000	48,131,000	61,585,000	-17,138,000	35,628,000	52,060,000	5,946,000	18,365,000	33,072,000	33,149,000	-5,588,000	9,475,000	14,295,000	14,170,000	4,076,000	2,751,000	21,919,000	20,635,000	15,177,000	36,554,000	-1,178,000	-4,629,000	5,714,000	13,690,000
adjustments to reconcile net increase in net assets resulting from operations to net cash from operating activities:
purchases of investments	-557,388,000	-415,033,000	-362,376,000	-224,976,000	-349,856,000	-605,239,000	-306,957,000	-355,333,000
fundings assigned to adviser funds			0	0	5,000,000	113,379,000	56,218,000
principal and fee repayments received
proceeds from the sale of debt investments
proceeds from the sale of equity and warrant investments	600,000	329,000	26,015,000	4,275,000	7,122,000	12,026,000
net change in unrealized (appreciation) depreciation	-47,790,000	25,565,000	-13,773,000	13,894,000	34,722,000	-3,634,000	-31,287,000
net realized (gain) loss	57,616,000	1,541,000	33,311,000	559,000	5,784,000	-8,168,000	-2,847,000
payments of derivative instruments				0
accretion of paid-in-kind interest	-13,635,000	-13,473,000	-13,400,000	-12,706,000	-15,267,000	-9,897,000
accretion of loan discounts	-2,534,000	-1,109,000	-1,476,000	-1,179,000	-1,080,000	-901,000	-1,595,000	-1,176,000	-1,328,000	-683,000	-1,198,000	-1,147,000	-1,097,000	-925,000	-773,000	-737,000	-953,000	-1,399,000	-799,000	-763,000	-1,469,000	-1,466,000	-1,852,000	-1,924,000	-1,913,000	-1,863,000	-1,680,000	-2,957,000	-2,056,000	-1,356,000	-2,102,000	-2,520,000	-3,430,000	-1,740,000	-990,000	-588,000	-1,034,000
accretion of loan discounts on convertible notes	311,000	68,000
loss on extinguishment of debt	21,000	15,000
accretion of loan exit fees	-7,845,000	-7,436,000	-6,894,000	-6,474,000	-6,551,000	-6,736,000	-10,821,000	-5,744,000	-6,470,000	-6,486,000	-6,427,000	-6,265,000	-6,697,000	-6,345,000	-6,054,000	-5,199,000	-4,543,000	-3,559,000	-4,516,000	-4,407,000	-4,685,000	-3,760,000	-4,079,000	-6,574,000	-5,737,000	-5,231,000	-4,454,000	-3,869,000	-3,857,000	-2,767,000	-10,787,000	-1,127,000			239,000	-568,000	-1,244,000
change in loan income, net of collections	11,509,000	4,365,000	8,610,000	3,918,000	6,452,000	4,529,000	8,447,000
unearned fees related to unfunded commitments	-1,685,000	1,102,000	-241,000	-676,000	-324,000	841,000	-2,371,000	-1,505,000	-321,000	718,000	-225,000	-463,000	-493,000	-2,000	906,000	992,000	-844,000	292,000	1,295,000	321,000	607,000	-328,000	-207,000	976,000	-26,000	-87,000	-1,793,000	-1,345,000	547,000	527,000	1,363,000	-2,003,000
amortization of debt fees and issuance costs	2,112,000	1,842,000	1,727,000	1,711,000	1,759,000	1,759,000	1,753,000	2,156,000	1,514,000	1,151,000	1,157,000	1,332,000	1,185,000	758,000	1,303,000	2,653,000	908,000	1,198,000	3,159,000	840,000	2,958,000	977,000	1,049,000	2,508,000	1,054,000	785,000	1,663,000	829,000	1,381,000	1,288,000	1,125,000	1,242,000
depreciation and amortization	81,000	89,000	93,000	91,000	96,000	186,000	23,000
stock-based compensation and amortization of restricted stock grants	3,698,000	3,637,000	3,207,000	3,228,000	3,238,000	2,812,000	3,069,000	2,516,000	2,141,000	2,124,000	2,126,000	2,082,000	1,548,000	1,239,000	2,550,000	3,305,000	3,100,000	3,123,000	2,724,000	2,319,000	1,628,000	1,842,000	1,927,000	1,850,000	1,628,000	2,596,000	2,230,000	2,204,000	2,286,000	2,741,000	2,733,000	2,844,000
change in operating assets and liabilities:
interest receivable	-1,736,000	-1,215,000	-1,129,000	69,000	3,865,000	-2,743,000	-684,000	-1,520,000																										22,000	353,000	-614,000	189,000
other assets	2,499,000	2,041,000	-5,935,000	10,930,000	-408,000	-2,915,000	-28,999,000	1,849,000
accrued liabilities	14,554,000	-19,345,000	7,669,000	-3,096,000	10,369,000	-1,254,000	7,766,000	-8,496,000	7,120,000	-804,000	5,745,000	-8,233,000	4,482,000	2,627,000	8,719,000	1,417,000	4,726,000	-3,266,000	7,009,000	-8,025,000	7,196,000	-3,355,000	6,153,000	-5,255,000	4,150,000	-5,029,000	-975,000	5,865,000	4,178,000	-3,978,000	2,620,000	646,000	-3,979,000	-870,000	3,451,000	-7,764,000	-1,076,000
net cash (used in) operating activities	-144,823,000	-222,197,000		92,555,000	59,492,000	-240,891,000
cash flows from investing activities:
purchases of capital equipment	-19,000	-8,000	-5,000	-30,000	-378,000	-292,000	-497,000	-12,000	-22,000	-48,000	-38,000	-29,000	-111,000	-243,000	-158,000	-83,000	-150,000	-209,000	-44,000	-72,000	-147,000	-38,000	-50,000	-39,000	-19,000	-127,000	-29,000	-78,000	-38,000	-42,000	-96,000	-37,000	-30,000	-27,000	-115,000	-50,000	-24,000
net cash (used in) investing activities	-19,000	-8,000	-5,000	-30,000	-378,000	-292,000
cash flows from financing activities:
issuance of common stock	150,753,000	40,160,000	153,600,000	0	0	67,275,000	100,738,000	-195,000	3,614,000	-96,000	38,699,000	34,963,000	37,445,000	-288,000	95,422,000	-43,000	893,000	30,872,000	106,674,000	5,952,000	10,601,000	9,423,000	-37,000	46,948,000	11,266,000	12,404,000	0	0	0	100,092,000
offering expenses	-1,319,000	-743,000	-1,555,000	-88,000	-36,000	-867,000	-833,000
retirement of employee shares	-1,026,000	-3,469,000	-1,035,000	-1,090,000	1,396,000	-2,701,000	-577,000	-1,039,000	-270,000	-389,000	-282,000	-896,000	-55,000	-4,213,000	-174,000	-676,000	-242,000	50,000	-241,000	-460,000	-243,000	-495,000	-555,000	-1,392,000	-619,000	-1,385,000	-569,000
distributions paid	-80,548,000	-78,873,000	-77,884,000	-75,498,000	-75,842,000	-74,251,000	-71,926,000	-41,755,000	-38,033,000	-35,634,000	-35,359,000	-43,396,000	-36,180,000	-35,011,000	-31,594,000	-29,268,000	-31,287,000	-29,191,000	-26,250,000	-25,993,000	-25,668,000	-25,009,000	-24,929,000	-25,279,000
issuance of debt	932,174,000	569,188,000	393,154,000	283,000,000	253,000,000	403,000,000	126,000,000	342,218,000
repayment of debt	-847,078,000	-360,812,000	-360,525,000	-292,000,000	-259,000,000	-207,000,000	-205,000,000
debt issuance costs	-6,113,000	-4,927,000						-1,842,000
fees paid for credit facilities	-3,026,000	-419,000
net cash from financing activities	143,817,000	160,105,000	101,653,000	-87,426,000	-80,482,000	185,456,000	-51,598,000	-100,375,000	-42,234,000	-10,127,000	1,245,000	-33,923,000	93,088,000	-17,198,000	112,102,000	122,406,000	133,977,000	-8,008,000	110,416,000	-36,078,000	41,790,000	-38,240,000	-39,278,000	128,031,000	45,762,000	-4,783,000	-12,397,000	-76,914,000	444,000	68,026,000	71,543,000	28,254,000	-92,375,000	-15,589,000	-4,348,000	-6,737,000	-10,277,000
net increase in cash, cash equivalents, foreign cash and restricted cash	-1,025,000	-62,100,000
cash, cash equivalents, foreign cash and restricted cash at beginning of period	0	116,421,000
cash, cash equivalents, foreign cash and restricted cash at end of period	-1,025,000	54,321,000
supplemental disclosures of cash flow information and non-cash investing and financing activities:
interest paid	11,428,000	25,580,000	13,629,000	28,685,000	11,452,000	24,084,000	9,739,000	17,359,000	12,065,000
income tax, including excise tax, paid	256,000	6,033,000	68,000	29,000	254,000	4,902,000	62,000	3,488,000	-20,000
distributions reinvested	2,535,000	2,511,000	2,492,000	2,445,000	2,052,000	1,780,000	1,688,000	1,040,000	946,000	923,000	643,000	827,000	669,000	544,000	557,000	632,000	635,000	518,000	428,000	426,000	422,000	658,000	734,000	388,000
principal and fee repayments received and proceeds from the sale of debt investments		144,483,000	233,738,000	234,276,000	313,568,000	174,100,000	317,330,000
payments for derivative instruments
accretion of loan discount on convertible notes								168,000	167,000	168,000	168,000	168,000	167,000	168,000	168,000	168,000	167,000	168,000	168,000	168,000	167,000	168,000	168,000	112,000
net cash from operating activities							130,877,000	-50,419,000	231,817,000	-11,247,000	11,934,000	-24,702,000	-13,912,000	24,772,000	-109,958,000	-141,566,000	-133,611,000	-21,489,000	-156,885,000	63,015,000	-95,029,000	9,021,000	55,902,000	11,706,000	453,000	-82,353,000	-35,849,000	101,857,000	-66,314,000	-114,055,000	7,581,000	13,007,000	-71,944,000	24,825,000	-48,571,000	-12,056,000
fees paid for credit facilities and debentures							0	-35,000	-1,041,000	-250,000	114,000	-2,433,000	-33,000	164,000	-554,000	-2,443,000	-68,000	-78,000			105,000	225,000	-1,000	-252,000	-1,166,000	-141,000	-338,000	-114,000	-268,000	100,000	-433,000	-752,000	421,000	-455,000	-1,036,000	-376,000
net increase in cash, cash equivalents, and restricted cash				5,099,000	-21,368,000	-55,727,000		-150,806,000		-21,422,000	13,141,000	-58,654,000
cash, cash equivalents, and restricted cash at beginning of period				0	0	116,013,000		237,622,000		0	0	114,996,000
cash, cash equivalents, and restricted cash at end of period				5,099,000	-21,368,000	60,286,000		86,816,000		-21,422,000	13,141,000	56,342,000
cash flows from (used in) operating activities:
proceeds from the sale of equity investments
accretion of paid-in-kind principal							-6,671,000	-2,475,000	-2,558,000	-2,251,000	-2,100,000	-2,130,000	-2,034,000	-2,261,000	-2,211,000	-2,099,000	-2,323,000	-2,344,000	-2,189,000	-2,507,000	-2,608,000	-2,422,000	-2,457,000	-2,199,000	-1,708,000	-1,535,000	-1,241,000	-1,212,000	-919,000	-665,000	-559,000	-653,000	-447,000	-890,000	-948,000	-568,000	-992,000
realized loss on extinguishment of debt
cash flows used in investing activities:
net increase in cash, cash equivalents and restricted cash													79,065,000	7,331,000	1,986,000	-19,243,000	216,000	-29,706,000	-46,513,000	26,865,000
cash, cash equivalents and restricted cash at beginning of period													0	0	0	45,857,000	0	0	0	94,995,000
cash, cash equivalents and restricted cash at end of period													79,065,000	7,331,000	1,986,000	26,614,000	216,000	-29,706,000	-46,513,000	121,860,000
net cash from investing activities								-12,000		-48,000	-38,000	-29,000	-111,000	-243,000	-158,000	-83,000	-150,000	-209,000	-44,000	-72,000	3,980,000	9,375,000	-4,352,000	-4,641,000	22,000	5,418,000	-3,862,000	6,374,000	10,101,000	-9,331,000		1,358,000	4,538,000	-1,815,000	-469,000	103,000	-68,000
purchases assigned to external funds								48,353,000
principal and fee payments received on investments								209,747,000	300,531,000	211,475,000	101,723,000	167,511,000	175,682,000	156,825,000	201,809,000	65,845,000	89,531,000	89,624,000	134,166,000	280,181,000	154,031,000	137,466,000	207,721,000	141,798,000	143,523,000	77,808,000	130,346,000	225,039,000	78,840,000	75,368,000
proceeds from the sale of investments								12,973,000	10,720,000	2,255,000	2,726,000	17,076,000	7,909,000	10,400,000	11,434,000	9,830,000	2,365,000	7,753,000	8,186,000	1,582,000	1,936,000	3,495,000	6,455,000	11,995,000	1,405,000	4,636,000	1,369,000	9,029,000	493,000	7,001,000	15,455,000
net unrealized (appreciation) depreciation on investments								-21,833,000
net realized (gain) loss on investments								-7,770,000
change in deferred loan origination revenue								13,414,000	4,794,000	8,322,000	2,345,000	1,319,000	4,560,000	2,830,000	7,033,000	3,754,000	2,623,000	57,000	2,784,000	631,000	-121,000	1,064,000	-265,000	284,000	-699,000	655,000	629,000	-483,000	218,000	1,540,000	335,000	-267,000	1,503,000	-1,852,000
depreciation								94,000	96,000	97,000	96,000	126,000	87,000	74,000	50,000	51,000	52,000	53,000	48,000	46,000	48,000	48,000	53,000	52,000	48,000	56,000	41,000	41,000	53,000	58,000	105,000	55,000	17,000	89,000	100,000	95,000	91,000
accounts payable									1,000	-1,000	0	-16,000	-9,000	-5,000	7,000	-198,000	198,000	-431,000	438,000	-194,000				1,000	144,000	-88,000	-810,000	903,000	-228,000	-504,000	-855,000	555,000	977,000	-406,000	181,000	-112,000	136,000
repayments of debt								-397,727,000
purchase of investments									-129,827,000	-265,541,000	-132,278,000	-233,612,000	-240,853,000	-177,011,000	-368,145,000	-239,702,000	-254,731,000	-142,369,000	-327,459,000	-236,285,000	-277,474,000	-146,689,000	-186,967,000	-153,665,000	-159,829,000	-170,921,000	-180,653,000	-158,626,000	-164,035,000	-209,387,000	-207,833,000	-128,562,000	-201,813,000	-85,024,000	-145,956,000	-88,108,000	-9,097,000
net unrealized depreciation (appreciation) on investments									-123,722,000	-52,834,000	-25,940,000	76,270,000	-1,622,000	24,409,000	-8,593,000	-27,997,000	47,122,000	-2,976,000	-38,197,000	15,197,000						1,334,000				-5,614,000	2,370,000	9,482,000
net realized gain on investments									14,712,000	48,501,000	-141,000	-6,967,000	-2,890,000	-4,807,000	-4,271,000	-4,555,000	606,000	-3,350,000	8,911,000	4,920,000	-218,000	24,454,000	5,712,000	-3,237,000	-25,000	4,468,000	3,277,000	-6,366,000	1,254,000	-3,312,000	-7,105,000	-5,664,000	-2,973,000	-4,370,000	-3,359,000	-362,000
interest and fees receivable									429,000	-48,000	-321,000	1,070,000	-361,000	-1,640,000	160,000	-1,407,000	-1,237,000	-1,314,000	-3,321,000	1,175,000	-1,755,000	-303,000	1,280,000	130,000	1,539,000	-1,753,000	-712,000	698,000	-124,000	351,000	-306,000	-446,000
prepaid expenses and other assets									2,646,000	-457,000	2,713,000	-4,100,000	1,913,000	-833,000	-2,181,000	-9,272,000	-3,240,000	1,623,000	-1,352,000	1,870,000	3,000	-1,689,000	1,650,000	-1,061,000	-6,501,000	-2,540,000	-7,000	2,089,000	70,000	2,674,000	7,459,000	-517,000	-1,495,000	2,071,000	440,000	-788,000	1,357,000
repurchase of common stock																									-1,000	-4,789,000	-147,000
issuance of july 2024 notes													0
issuance of april 2025 notes
issuance of 2033 notes																	0
issuance of 2027 asset-backed notes
issuance of 2028 asset-backed notes													0	0	0	250,000,000
issuance of february 2025 notes									0	0	0	50,000,000
issuance of june 2025 notes									0	0
issuance of march 2026 notes tranche a
repayments of 2024 notes													0	0	0	-83,510,000	0	0
repayment of 2018 asset-backed notes
repayments of 2021 asset-backed notes																	-3,516,000	-27,572,000	-2,488,000	-15,577,000	-16,324,000	-22,202,000	-13,733,000	-7,794,000
repayments of long-term sba debentures									0	-11,250,000	0	-38,750,000					0														0	0
borrowings of credit facilities									160,392,000	168,794,000	83,262,000	242,026,000	206,392,000	75,642,000	294,358,000	110,834,000	137,488,000	65,409,000			0	0	0	8,497,000	64,319,000	106,666,000								18,750,000			16,019,000
repayments of credit facilities									-197,884,000	-131,302,000	-154,388,000	-274,819,000	-114,058,000	-157,478,000	-245,204,000	-119,523,000	-165,425,000	-42,839,000			0	0	0	-13,513,000	-125,322,000	-95,663,000	-35,324,000	-52,987,000						-25,000,000			-16,436,000
cash paid for debt issuance costs									0	0	-801,000	-618,000	-423,000	-1,014,000	-152,000	-2,965,000	196,000	-3,459,000			-1,680,000	-182,000	-24,000	-4,456,000
issuance of 2022 convertible notes
issuance of 2022 notes
issuance of 2024 notes
issuance of 2025 notes																	0	0
repayments of 2019 notes
supplemental non-cash investing and financing activities:
cash paid for redemption of convertible notes
income taxes paid
loss on debt extinguishment																											0	0	0	1,000
payment of loan discount on convertible notes
reduction of restricted cash																					4,127,000
issuance of convertible notes																					0	0	0	230,000,000
repayments of 2017 asset-backed notes																											0	0	-4,203,000	-11,846,000
net increase in cash and cash equivalents																					-49,259,000	-19,844,000	12,272,000	135,096,000
cash and cash equivalents at beginning of period																					0	0	0	13,044,000	0	95,196,000	0	0	0	227,116,000	0	0	161,354,000	107,014,000	0	124,828,000	0
cash and cash equivalents at end of period																					-49,259,000	-19,844,000	12,272,000	148,140,000	46,237,000	13,478,000	-52,108,000	31,317,000	-55,769,000	171,756,000	68,489,000	42,619,000	1,573,000	114,435,000	-53,387,000	106,138,000	39,880,000
net unrealized appreciation (depreciation) on investments																																				260,000
issuance of 2024 notes payable																						0	0	5,637,000
repayments of 2019 notes payable																						0	1,000	-110,365,000				0
net unrealized depreciation on investments																							-13,587,000	31,503,000				25,880,000						15,352,000			-17,517,000
reduction of (increase in) restricted cash																							-4,302,000	-4,602,000
reduction of (investment in) restricted cash																													10,139,000	-9,289,000	-10,564,000	1,395,000
other long-term assets																																		-1,788,000	-354,000	153,000	-44,000
issuance of 2021 asset-backed notes
net decrease in cash and cash equivalents																									46,237,000	-81,718,000		31,317,000	-55,769,000	-55,360,000	68,489,000	42,619,000
accretion of loan discount on convertible senior notes																									21,000	61,000	61,000	62,000	61,000	62,000	105,000	197,000
payment of loan discount on convertible senior notes																											0	0	-3,000	-2,000
dividend distributions paid
cash paid for redemption of convertible senior notes																											0	0	-35,000	-30,000	-21,554,000
dividend distributions reinvested
reduction of (investments in) restricted cash																										5,545,000
dividends paid																										-21,875,000	-21,343,000	-22,082,000	-21,863,000	-19,704,000	-19,746,000	-19,439,000	-29,001,000	-8,890,000		-6,510,000	-9,713,000
dividends reinvested																										496,000	857,000	390,000	637,000	562,000	333,000	488,000
borrowings on credit facilities
issuance (retirement) of employee shares																													-2,809,000	-586,000
paid-in-kind principal																													656,000	1,356,000	709,000	653,000
proceeds from issuance (repurchase of employee shares due to restricted stock vesting) of common stock																															-798,000	-1,037,000
issuance of 2019 notes payable
issuance of 2017 asset-backed notes
principal payments received on investments																																115,839,000	114,716,000	85,988,000	79,502,000	77,983,000	50,853,000
loss on conversion of convertible senior notes
repayments of asset-backed notes																																-18,596,000
proceeds from sale of investments																																	-6,626,000	16,897,000	5,736,000	2,090,000	1,252,000
adjustments to reconcile net increase in net assets resulting from operations to net cash from and provided by operating activities:
stock-based compensation																																		167,000	190,000	176,000	499,000
amortization of restricted stock grants																																		569,000	584,000	305,000
income tax payable/receivable
proceeds from issuance of common stock																																		6,000	195,000	383,000
stock repurchase program																																			-3,465,000	-234,000
net increase in cash																																		7,421,000	-53,388,000	-18,690,000	39,880,000
common stock issued for director compensation
amortization of deferred loan origination revenue																																			-542,000	-639,000	-1,118,000
income tax payable																																			0	8,000	-4,000
deferred loan origination revenue																																			2,225,000	1,424,000	52,000
dividends paid, net of dividends reinvested
common stock issued in lieu of director compensation																																					14,000
net realized appreciation paid to lender
net cash from (used in ) operating activities
net unrealized appreciation due to lender

We provide you with 20 years of cash flow statements for Hercules Capital stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Hercules Capital stock. Explore the full financial landscape of Hercules Capital stock with our expertly curated income statements.

The information provided in this report about Hercules Capital stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.